|
1
|
Heck JE, Meyers TJ, Lombardi C, Park AS,
Cockburn M, Reynolds P and Ritz B: Case-control study of birth
characteristics and the risk of hepatoblastoma. Cancer Epidemiol.
37:390–395. 2013. View Article : Google Scholar :
|
|
2
|
Stiller CA, Pritchard J and
Steliarova-Foucher E: Liver cancer in European children: Incidence
and survival, 1978–1997. Report from the Automated Childhood Cancer
Information System project. Eur J Cancer. 42:2115–2123. 2006.
View Article : Google Scholar
|
|
3
|
Czaudernaa P, Haeberle B, Hiyama E,
Rangaswami A, Krailo M, Maibach R, Rinaldi E, Feng YR, Aronson D,
Malogolowkin M, et al: The Children's Hepatic tumors International
Collaboration (CHIC): Novel global rare tumor database yields new
prognostic factors in hepatoblastoma and becomes a research model.
Eur J Cancer. 52:92–101. 2016. View Article : Google Scholar
|
|
4
|
Tanimura M, Matsui I, Abe J, Ikeda H,
Kobayashi N, Ohira M, Yokoyama M and Kaneko M: Increased risk of
hepatoblastoma among immature children with a lower birth weight.
Cancer Res. 58:3032–3035. 1998.
|
|
5
|
Pateva IB, Egler RA and Stearns DS:
Hepatoblastoma in an 11-year-old. Case report and a review of the
literature. Medicine (Baltimore). 96:e58582017. View Article : Google Scholar :
|
|
6
|
Park KW, Seo CJ, Yun DY, Kim MK, Kim BS,
Han YS, Oh KH and Lee CH: A case of hepatoblastoma misdiagnosed as
combined hepatocellular carcinoma and cholangiocarcinoma in an
adult. Clin Mol Hepatol. 21:300–308. 2015. View Article : Google Scholar :
|
|
7
|
Maniotis AJ, Folberg R, Hess A, Seftor EA,
Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ: Vascular
channel formation by human melanoma cells in vivo and in vitro:
Vasculogenic mimicry. Am J Pathol. 155:739–752. 1999. View Article : Google Scholar :
|
|
8
|
Zhang S, Guo H, Zhang D, Zhang W, Zhao X,
Ren Z and Sun B: Microcirculation patterns in different stages of
melanoma growth. Oncol Rep. 15:15–20. 2006.
|
|
9
|
Sood AK, Seftor EA, Fletcher MS, Gardner
LM, Heidger PM, Buller RE, Seftor RE and Hendrix MJ: Molecular
determinants of ovarian cancer plasticity. Am J Pathol.
158:1279–1288. 2001. View Article : Google Scholar :
|
|
10
|
Fujimoto A, Onodera H, Mori A, Nagayama S,
Yonenaga Y and Tachibana T: Tumour plasticity and extravascular
circulation in ECV304 human bladder carcinoma cells. Anticancer
Res. 26:59–69. 2006. View Article : Google Scholar
|
|
11
|
Baeten CI, Hillen F, Pauwels P, de Bruine
AP and Baeten CG: Prognostic role of vasculogenic mimicry in
colorectal cancer. Dis Colon Rectum. 52:2028–2035. 2009. View Article : Google Scholar
|
|
12
|
Li M, Gu Y, Zhang Z, Zhang S, Zhang D,
Saleem AF, Zhao X and Sun B: Vasculogenic mimicry: A new prognostic
sign of gastric adenocarcinoma. Pathol Oncol Res. 16:259–266. 2010.
View Article : Google Scholar
|
|
13
|
Wu S, Yu L, Cheng Z, Song W, Zhou L and
Tao Y: Expression of maspin in non-small cell lung cancer and its
relationship to vasculogenic mimicry. J Huazhong Univ Sci Technolog
Med Sci. 32:346–352. 2012. View Article : Google Scholar
|
|
14
|
Van der Schaft DW, Hillen F, Pauwels P,
Kirschmann DA, Castermans K, Egbrink MG, Tran MG, Sciot R, Hauben
E, Hogendoorn PC, et al: Tumor cell plasticity in Ewing sarcoma, an
alternative circulatory system stimulated by hypoxia. Cancer Res.
65:11520–11528. 2005. View Article : Google Scholar
|
|
15
|
Vartanian AA, Stepanova EV, Gutorov SL,
Solomko ESh, Grigorieva IN, Sokolova IN, Baryshnikov AY and
Lichinitser MR: Prognostic significance of periodic
acid-Schiff-positive patterns in clear cell renal cell carcinoma.
Can J Urol. 16:4726–4732. 2009.
|
|
16
|
Francescone R, Scully S, Bentley B, Yan W,
Taylor SL, Oh D, Moral L and Shao R: Glioblastoma-derived tumor
cells induce vasculogenic mimicry through Flk-1 protein activation.
J Biol Chem. 287:24821–24831. 2012. View Article : Google Scholar :
|
|
17
|
Folberg R and Maniotis AJ: Vasculogenic
mimicry. APMIS. 112:508–525. 2004. View Article : Google Scholar
|
|
18
|
Hendrix MJ, Seftor EA, Hess AR and Seftor
RE: Vasculogenic mimicry and tumour-cell plasticity: Lessons from
melanoma. Nat Rev Cancer. 3:411–421. 2003. View Article : Google Scholar
|
|
19
|
Cascone T and Heymach JV: Targeting the
angiopoietin/Tie2 pathway: Cutting tumor vessels with a
double-edged sword? J Clin Oncol. 30:441–444. 2012. View Article : Google Scholar
|
|
20
|
Jain RK, Duda DG, Clark JW and Loeffler
JS: Lessons from phase III clinical trials on anti-VEGF therapy for
cancer. Nat Clin Pract Oncol. 3:24–40. 2006. View Article : Google Scholar
|
|
21
|
Goel S, Duda DG, Xu L, Munn LL, Boucher Y,
Fukumura D and Jain RK: Normalization of the vasculature for
treatment of cancer and other diseases. Physiol Rev. 91:1071–1121.
2011. View Article : Google Scholar :
|
|
22
|
Zhang Y, Zhang Z, Li J, Li L, Han X, Han
L, Hu L, Wang S, Zhao Y, Li X, et al: Long-term efficacy and safety
of arsenic trioxide for first-line treatment of elderly patients
with newly diagnosed acute promyelocytic leukemia. Cancer.
119:115–125. 2013. View Article : Google Scholar
|
|
23
|
Breitenbach Lallemand V, Guillemin MC,
Janin A, Daniel MT, Degos L, Kogan SC, Bishop JM and de Thé H:
Retinoic acid and arsenic synergize to eradicate leukemic cells in
a mouse model of acute promyelocytic leukemia. J Exp Med.
189:1043–1052. 1999. View Article : Google Scholar :
|
|
24
|
Pettersson HM, Pietras A, Persson
Munksgaard M, Karlsson J, Johansson L, Shoshan MC and Påhlman S:
Arsenic trioxide is highly cytotoxic to small cell lung carcinoma
cells. Mol Cancer Ther. 8:160–170. 2009. View Article : Google Scholar
|
|
25
|
Yu J, Qian HL, Li Y, Wang Y, Zhang X,
Liang X, Fu M and Lin C: Arsenic trioxide
(As2O3) reduces the invasive and metastatic
properties of cervical cancer cells in vitro and in vivo. Gynecol
Oncol. 106:400–406. 2007. View Article : Google Scholar
|
|
26
|
Du J, Zhou N, Liu H, Jiang F, Wang Y, Hu
C, Qi H, Zhong C, Wang X and Li Z: Arsenic induces functional
re-expression of estrogen receptor α by demethylation of DNA in
estrogen receptor-negative human breast cancer. PLoS One.
7:e359572012. View Article : Google Scholar :
|
|
27
|
Munshi NC, Tricot G, Desikan R, Badros A,
Zangari M, Toor A, Morris C, Anaissie E and Barlogie B: Clinical
activity of arsenic trioxide for the treatment of multiple myeloma.
Leukemia. 16:1835–1837. 2002. View Article : Google Scholar
|
|
28
|
Ma ZB, Xu HY, Jiang M, Yang YL, Liu LX and
Li YH: Arsenic trioxide induces apoptosis of human gastrointestinal
cancer cells. World J Gastroenterol. 20:5505–5510. 2014. View Article : Google Scholar :
|
|
29
|
Alarifi S, Ali D, Alkahtani S, Siddiqui MA
and Ali BA: Arsenic trioxide-mediated oxidative stress and
genotoxicity in human hepatocellular carcinoma cells. Onco Targets
Ther. 6:75–84. 2013.
|
|
30
|
Lee JC, Lee HY, Moon CH, Lee SJ, Lee WH,
Cha HJ, Park SC, Lee YH, Park HJ, Song HT and Min YJ: Arsenic
trioxide as a vascular disrupting agent: Synergistic effect with
irinotecan on tumor growth delay in a CT26 allograft model. Transl
Oncol. 6:83–91. 2013. View Article : Google Scholar :
|
|
31
|
Xiao YF, Wu DD, Liu SX, Chen X and Ren LF:
Effect of arsenic trioxide on vascular endothelial cell
proliferation and expression of vascular endothelial growth factor
receptors Flt-1 and KDR in gastric cancer in nude mice. World J
Gastroenterol. 13:6498–6505. 2007. View Article : Google Scholar :
|
|
32
|
Thomas-Schoemann A, Batteux F, Mongaret C,
Nicco C, Chéreau C, Annereau M, Dauphin A, Goldwasser F, Weill B,
Lemare F and Alexandre J: Arsenic trioxide exerts antitumor
activity through regulatory T cell depletion mediated by oxidative
stress in a murine model of colon cancer. J Immunol. 189:5171–5177.
2012. View Article : Google Scholar
|
|
33
|
Verma RJ, Vasu A and Sayyed AA: Arsenic
toxicity in mice and its possible amelioration. J Environ Sci
(China). 16:447–453. 2004.
|
|
34
|
Sun B, Zhang S, Zhang D, Du J, Guo H, Zhao
X, Zhang W and Hao X: Vasculogenic mimicry is associated with high
tumor grade, invasion and metastasis, and short survival in
patients with hepatocellular carcinoma. Oncol Rep. 16:693–698.
2006.
|
|
35
|
Zhao N, Sun H, Sun B, Zhu D, Zhao X, Wang
Y, Gu Q, Dong X, Liu F, Zhang Y and Li X: miR-27a-3p suppresses
tumor metastasis and VM by down-regulating VE-cadherin expression
and inhibiting EMT: An essential role for Twist-1 in HCC. Sci Rep.
6:230912016. View Article : Google Scholar :
|
|
36
|
Hendrix MJ, Seftor EA, Meltzer PS, Gardner
LM, Hess AR, Kirschmann DA, Schatteman GC and Seftor RE: Expression
and functional significance of VE-cadherin in aggressive human
melanoma cells: Role in vasculogenic mimicry. Proc Natl Acad Sci
USA. 98:8018–8023. 2001. View Article : Google Scholar :
|
|
37
|
Bell D, Ranganathan S, Tao J and Monga SP:
Novel advances in understanding of molecular pathogenesis of
hepatoblastoma: A Wnt/β-catenin perspective. Gene Expr. 17:141–154.
2017. View Article : Google Scholar
|
|
38
|
Dong R, Liu GB, Liu BH, Chen G, Li K,
Zheng S and Dong KR: Targeting long non-coding RNA-TUG1 inhibits
tumor growth and angiogenesis in hepatoblastoma. Cell Death Dis.
7:e22782016. View Article : Google Scholar :
|
|
39
|
Czauderna P, Lopez-Terrada D, Hiyama E,
Häberle B, Malogolowkin MH and Meyers RL: Hepatoblastoma state of
the art: Pathology, genetics, risk stratifcation, and chemotherapy.
Curr Opini Pediatr. 26:19–28. 2014. View Article : Google Scholar
|
|
40
|
Sun T, Zhao N, Zhao XL, Gu Q, Zhang SW,
Che N, Wang XH, Du J, Liu YX and Sun BC: Expression and functional
significance of Twist1 in hepatocellular carcinoma: Its role in
vasculogenic mimicry. Hepatology. 51:545–556. 2010. View Article : Google Scholar
|
|
41
|
López-Terrada D, Cheung SW, Finegold MJ
and Knowles BB: HepG2 is a hepatoblastoma-derived cell
line. Hum Pathol. 40:1512–1515. 2009. View Article : Google Scholar
|
|
42
|
Xia Z, Zhang N and Ding DK: Proliferation
and migration of hepatoblastoma cells are mediated by IRS-4 via
PI3K/Akt pathways. Int J Clin Exp Med. 7:3763–3769. 2014.
|
|
43
|
Sood AK, Fletcher MS, Coffin JE, Yang M,
Seftor EA, Gruman LM, Gershenson DM and Hendrix MJ: Functional role
of matrix metalloproteinases in ovarian tumor cell plasticity. Am J
Obstet Gynecol. 190:899–909. 2004. View Article : Google Scholar
|
|
44
|
Zhang S, Zhang D and Sun B: Vasculogenic
mimicry: Current status and future prospects. Cancer Lett.
254:157–164. 2007. View Article : Google Scholar
|
|
45
|
Chang C and Werb Z: The many faces of
metalloproteases: Cell growth, invasion, angiogenesis and
metastasis. Trends Cell Biol. 11:S37–S43. 2001. View Article : Google Scholar :
|
|
46
|
Chen LX, He YJ, Zhao SZ, Wu JG, Wang JT
and Zhu LM: Inhibition of tumor growth and vasculogenic mimicry by
curcumin through downregulation of the EphA2/PI3K/MMP pathway in a
murine choroidal melanoma model. Cancer Biol Ther. 11:229–235.
2011. View Article : Google Scholar
|
|
47
|
Jinga DC, Blidaru A, Condrea I, Ardeleanu
C, Dragomir C, Szegli G, Stefanescu M and Matache C: MMP-9 and
MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast
cancer: Correlations with prognostic factors. J Cell Mol Med.
10:499–510. 2006. View Article : Google Scholar
|
|
48
|
Mönig SP, Baldus SE, Hennecken JK,
Spiecker DB, Grass G, Schneider PM, Thiele J, Dienes HP and
Hölscher AH: Expression of MMP-2 is associated with progression and
lymph node metastasis of gastric carcinoma. Histopathology.
39:597–602. 2001. View Article : Google Scholar
|
|
49
|
Kirschmann DA, Seftor EA, Hardy KM, Seftor
RE and Hendrix MJ: Molecular pathways: Vasculogenic mimicry in
tumor cells: Diagnostic and therapeutic implications. Clin Cancer
Res. 18:2726–2732. 2012. View Article : Google Scholar :
|
|
50
|
Øra I, Bondesson L, Jönsson C, Ljungberg
J, Pörn-Ares I, Garwicz S and Pâhlman S: Arsenic trioxide inhibits
neuroblastoma growth in vivo and promotes apoptotic cell death in
vitro. Biochem Biophys Res Commun. 277:179–185. 2000. View Article : Google Scholar
|
|
51
|
Siu KP, Chana JY and Fung KP: Effect of
arsenic trioxide on human hepatocellular carcinoma HepG2 cells:
Inhibition of proliferation and induction of apoptosis. Life Sci.
71:275–285. 2002. View Article : Google Scholar
|
|
52
|
Wang Y, Bai C, Guan H, Chen R, Wang X,
Wang B, Jin H and Piao F: Subchronic exposure to arsenic induces
apoptosis in the hippocampus of the mouse brains through the
Bcl-2/Bax pathway. J Occup Health. 57:212–221. 2015. View Article : Google Scholar
|
|
53
|
Venkatramani R, Furman WL, Fuchs J,
Warmann SW and Malogolowkin MH: Current and future management
strategies for relapsed or progressive hepatoblastoma. Paediatr
Drugs. 14:221–232. 2012. View Article : Google Scholar
|
|
54
|
von Schweinitz D: Management of liver
tumors in childhood. Semin Pediatr Surg. 15:17–24. 2006. View Article : Google Scholar
|
|
55
|
Zheng MH, Zhang L, Gu DN, Shi HQ, Zeng QQ
and Chen YP: Hepatoblastoma in adult: Review of the literature. J
Clin Med Res. 1:13–16. 2009.
|
|
56
|
Miller WH Jr, Schipper HM, Lee JS, Singer
J and Waxman S: Mechanisms of action of arsenic trioxide. Cancer
Res. 62:3893–3903. 2002.
|
|
57
|
Von Schweinitz D, Hecker H,
Schmidt-von-Arndt G and Harms D: Prognostic factors and staging
systems in childhood hepatoblastoma. Int J Cancer. 74:593–599.
1997. View Article : Google Scholar
|
